Fecha de publicación: -- Fuente: Labiotech Lugar: In Depth GLP-1 agonists go beyond treating metabolic disease. They have shown promise in treating MASH, addiction, sleep apnea, and neurodegeneration.
The post What can GLP-1s do beside treat diabetes and obesity? appeared first on Labiotech.eu.
© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.